Showing results (221-230 of 237) with videos related to
Sort By:
Pageof 24
Bioorganic & Medicinal Chemistry|July 1, 1997
Trioxane dimers have potent antimalarial, antiproliferative and antitumor activities in vitroG H Posner, P Ploypradith, W Hapangama, et al.Plos One|May 26, 2017
SNP in human ARHGEF3 promoter is associated with DNase hypersensitivity, transcript level and platelet function, and Arhgef3 KO mice have increased mean platelet volumeSiying Zou, Alexandra M Teixeira, Myrto Kostadima, et al.Archives of Pathology & Laboratory Medicine|December 3, 1999
Higher prevalence of GPIIIa PlA2 polymorphism in siblings of patients with premature coronary heart diseaseP J Goldschmidt-Clermont, L D Coleman, Y M Pham, et al.Blood|August 27, 2020
miR-125a-5p regulates megakaryocyte proplatelet formation via the actin-bundling protein L-plastinSeema Bhatlekar, Bhanu K Manne, Indranil Basak, et al.Circulation Research|December 20, 2019
Longitudinal RNA-Seq Analysis of the Repeatability of Gene Expression and Splicing in Human Platelets Identifies a Platelet SELP Splice QTLMatthew T Rondina, Deepak Voora, Lukas M Simon, et al.Circulation|May 17, 2006
Effects of conjugated equine estrogen on stroke in the Women's Health InitiativeSusan L Hendrix, Sylvia Wassertheil-Smoller, Karen C Johnson, et al.Clinical Cardiology|November 1, 1996
Refining the treatment of women with unstable angina--a randomized, double-blind, comparative safety and efficacy evaluation of Integrelin versus aspirin in the management of unstable anginaP J Goldschmidt-Clermont, S P Schulman, P F Bray, et al.Blood|August 5, 2022
MAPK-interacting kinase 1 regulates platelet production, activation, and thrombosisBhanu Kanth Manne, Robert A Campbell, Seema Bhatlekar, et al.Circulation|May 3, 2012
Human genome-wide association and mouse knockout approaches identify platelet supervillin as an inhibitor of thrombus formation under shear stressLeonard C Edelstein, Elizabeth J Luna, Ian B Gibson, et al.Blood Cells, Molecules & Diseases|July 30, 2018
Effects of genetic variation in protease activated receptor 4 after an acute coronary syndrome: Analysis from the TRACER trialPierluigi Tricoci, Megan Neely, Michael J Whitley, et al.Pageof 24